Unlocking Immunotherapy: Insights into Treating Rare Eye Cancer
New research from the University of Pittsburgh sheds light on why conventional immunotherapies struggle to combat metastatic uveal melanoma and highlights the efficacy of adoptive therapy, where a patient’s T … Read More